| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Classified under Pharmaceuticals (Health Care sector), SHPH's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 0 | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 14, 2026 | Hrt Financial LP46 | 10% Owner | Sell | 83,149 | $4.48 | $372,703.79 | -100% | - | - | |
| Jul 10, 2026 | Hrt Financial LP46 | 10% Owner | Buy | 8,997 | $3.36 | $30,212.49 | +17.2% | - | - | |
| Jul 8, 2026 | Hrt Financial LP46 | 10% Owner | Sell | 29,111 | $3.45 | $100,460.52 | -35.8% | - | - | |
| Jul 6, 2026 | Hrt Financial LP46 | 10% Owner | Sell | 9,022 | $3.51 | $31,667.22 | -10.0% | - | - | |
| Jul 2, 2026 | Hrt Financial LP46 | 10% Owner | Buy | 7,851 | $3.54 | $27,792.54 | +9.5% | - | - | |
| Jul 1, 2026 | Hrt Financial LP46 | 10% Owner | Buy | 3,959 | $3.30 | $13,064.70 | +5.0% | - | - | |
| Jun 30, 2026 | Hrt Financial LP46 | 10% Owner | Buy | 32,591 | $3.40 | $110,694.49 | +70.8% | - | - | |
| Dec 13, 2023 | Brown Milton | Director | Sell | 2,921 | $0.46 | $1,353.01 | -0.3% | -9.9% | -81.4% | |
| Dec 13, 2023 | Jacobs Bette | Director | Sell | 4,157 | $0.46 | $1,925.52 | -13.3% | -9.9% | -81.4% | |
| Dec 29, 2022 | Jacobs Bette | Director | Sell | 4,366 | $1.61 | $7,007.43 | -12.3% | -24.6% | -72.8% |